Claritin Maker Sued Over Ads

WASHINGTON–A Boston consumer group filed a class-action suit Thursday against Schering-Plough Corporation, the maker of Claritin, alleging the company has used deceptive and unfair advertising to increase demand for the drug.

The Prescription Access Litigation Project filed the suit in Superior Court in New Jersey. “We believe Schering-Plough has deliberately left out any information about the drug?s efficacy, instead serving up glowing ads to push this product in America?s living rooms,” said Stephen Rosenfeld, the group’s spokesman.

A Schering-Plough rep said the company has not yet reviewed the complaint, but is committed to complying with all Food and Drug Administration requirements regarding direct-to-consumer ads.